Objectives: Immunisation is crucial to population health. This study aimed to identify the information needs and concerns of health consumers regarding childhood vaccination.
V accines are extremely successful in providing protection against numerous infectious diseases; 1 and constitute a vital part of preventive health care delivery. For example, global mortality due to measles decreased by 74%, from 535,300 deaths in 2000 to 139,300 in 2010, in parallel with a rise in the immunisation rate from 72% to 85%. 2 Successful vaccination strategies rely on high immunisation rates at the population level to achieve herd immunity. The World Health Organization's (WHO) global vaccine action plan aims for vaccine coverage of at least 90% nationwide, and at least 80% in every district or equivalent unit. 1 In Australia, 92.2% of five-year-olds are fully immunised. 3 However, there are still numerous areas with immunisation rates below 80%, sometimes as low as 44%. 4 In countries where vaccines are freely and easily accessible, parental concerns or misinformation can act as barriers to meeting WHO targets. [5] [6] [7] [8] As all parents have to consider immunising their children, it is not surprising that the need for information about vaccines is high. 9 Nearly half the parents search for additional information, 9 using a wide range of information sources. The most frequent sources are doctors, pharmacists, nurses, patient information leaflets and the Internet. 10-12, A respectful approach from a healthcare professional with a good relationship with the patient is the main reason for hesitant parents to change their mind concerning childhood vaccination. 13 Medicines call centres (MCCs) using health professionals as information providers are also perceived as a valuable source of information. [14] [15] [16] [17] By analysing calls from consumers to a national medicines call centre in Australia, we aimed to better understand the information needs related to childhood immunisation. Awareness of information gaps can assist healthcare professionals to proactively address the concerns of vaccine hesitant parents and carers.
Methods
We analysed data relating to childhood vaccines from the NPS MedicineWise 
Data extraction
All medicines involved in the calls were coded using the World Health Organization (WHO) Anatomical Therapeutic Chemical (ATC) classification system. 18 Vaccine calls were extracted from the MCC database at ATC level 2; group J07, i.e. "vaccines". These are referred to as 'vaccination-related calls'; and include bacterial, viral, combined and other vaccines. The remainder of calls involving medicines outside this class are referred to as 'rest of calls' . Records from callers only requesting a CMI leaflet were omitted from the analyses.
To assess 'childhood' vaccination, we extracted calls relating to vaccines in patients up to the age of five years. We restricted the calls to children in this age group so data could be compared with the Australian National Immunisation Program (NIP). This program provides data at specific time points in the first five years of life (birth; two, four, six, 12, 18 months; and four years of age). Of these calls, 85 were excluded from further analyses as the question was about the possible effect on the child from a vaccine given to their parent. Caller location was identified by postal code and grouped by state/territory and Accessibility Remoteness Index of Australia (ARIA), a measure of the remoteness of areas from service centres.
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Information on immunisation rates in Australia was retrieved using data from the National Health Performance Authority (NHPA) 4 and linked with caller postcode. Based on the WHO goals of a 90% immunisation rate, we defined two groups: a high immunisation rate group (including all calls from postcodes with an immunisation rate of 90% and higher), and a low immunisation rate group (below 90%). Additionally, we used the NIP to group specific vaccine-combinations. 4 
Analysis of the narratives
The pharmacist handling the call manually recorded pertinent background information on the data collection form, from which the caller's primary question was derived. From the calls related to childhood vaccination, we selected all calls for which a narrative of the question was available electronically (from 2007 onwards). We also manually entered question narratives from the paper records before 2007 into the electronic database until no new topics or issues were apparent. Two authors (MM and SK), identified themes from the narratives independently. The identified themes were compared, and any discrepancies were discussed until consensus was reached. Subsequently, themes were collapsed into overarching categories. We compared these themes between the high and the low vaccination rate groups and for specific vaccine questions over time. 
Results

Quantitative analysis
Description of the data Of the total vaccine-related calls, 74% were for children up to five years of age; 34% of these calls were for children less than a year old. The most common motivations to call the MCC were 'inadequate information' (54%), 'second opinion' (21%) 'conflicting information' (9%) and 'worrying symptom' (6%).
Demographics
The In addition to the overarching categories, other interesting themes emerged. These expanded themes were explored for all vaccine-related questions and compared across the top five ranked vaccines within question narrative sub-set: influenza, MMR (mumps, measles and rubella), hepatitis B, varicella and pneumococcal vaccines (Table  1) . While excipients, as a constituent, posed consumer concern for all vaccines; seeking clarity or reassurance prior to immunising children with egg allergy was a common query in relation to influenza, the combined measles and varicella vaccines. The influenza vaccine and, to a lesser degree, the hepatitis B vaccine generated many questions around the need for and safety of repeated vaccines.
Consumers also wondered if their child needed these vaccines or not. While logistics made up a wide range of questions, the most common concern was around the availability of single vaccines; many were exploring options to give single vaccines instead of the combined MMR vaccine.
A recurrent parental concern related to use of antibiotics around the time of immunisation, e. A time trend for narrative questions relating to inclusion of mercury or thiomersal in vaccines highlights that concern persists, despite such preservatives being removed from vaccines in Australia in 2000 (Figure 1) . Similarly, the time trends of questions about pneumococcal and varicella vaccines link well with their introduction to the Australian market and the NIP; while questions related to influenza have a more consistent pattern in line with strain inclusions being regularly changed.
Differences between low and high immunisation areas
There were 607 calls (45.2%) from areas with low immunisation rates (with 232 narratives available) and a total of 693 calls (51.6%) calls from areas with high immunisation rates (with 262 narratives available). No postcode was available for 42 calls. Of the individual themes identified, the four most common topics are shown in Table 2 for the high and low vaccine areas. In general, both groups had many questions about constituents of vaccines, with the theme 'constituents (egg)' including people specifically asking if there are traces of egg in vaccines, e.g. related to allergies, diets or general interest. The group 'other constituents' was very broad, e.g. questions about the possible presence of blood products, antibiotics or numerous other constituents in a vaccine. However, the low immunisation rate group was significantly more likely to ask if mercury and/ or thiomersal are still present in vaccines.
interviews with parents. 28 In response to a trigger such as a media report about a vaccine or a request to consent for their child to be immunised, uncertainty is generated and leads care-givers to one of three alternative actions: a routine response to immunise without considering the pros and cons, an emotional response, and delaying the decision by entering a questioning stage followed by a cyclical process of seeking and evaluating information. 
Discussion
The predominance of female callers of reproductive age asking about not only childhood vaccines but also other paediatric medication issues is consistent with literature suggesting that females are more likely to proactively help seek than males, [21] [22] [23] [24] particularly for a family member irrespective of the medical topic. 21, 25 It also aligns with data from other MCCs. 26, 27 The consistency of our caller and patient data across both vaccine-related and other medicines-related calls also suggests that the care-giver drive for these women to help-seek for their young child is strong, irrespective of the individual medicine involved.
In our study, the frequency of informationseeking about childhood vaccination was comparable for care-givers from both high and low immunisation areas. These are the 'questioning care-givers'; and this is consistent with a model of vaccination decision-making, developed by Sporton and Francis after conducting semi-structured Parent and carer concerns impact on vaccine hesitancy. [5] [6] [7] 13, 33 Our study found that vaccine safety is still a major concern for parents; and the possible negative consequences of vaccines acts as a barrier in the decision to immunise or not. The National Survey of Australian Public Attitudes to Vaccination (NSAPAtoV) shows that the key information needs in Australia are side effects, risks and safety testing. 34 While our study demonstrated a similar consumer concern about vaccine safety in general; safety testing of vaccines did not emerge as a concern for MCC callers. This disparity might be explained by the demographics of participants and measures used to collect the data. In the NSAPAtoV, adults of a wide age range were asked specific questions about their concerns towards immunisation. In contrast, our study population were help seeking consumers, primarily female parents or carers, with real world information gaps about vaccines often at a time where they would have to decide whether or not to vaccinate their child.
When we take a closer look at the callers' safety issues, the potential presence of mercury and thiomersal as preservatives was the most common concern, particularly for those living in low immunisation rate areas (p≤0.05). Thiomersal (a mercury-based preservative) was removed from childhood vaccines in Australia in 2000, 35 before our data was collected. The fact that this issue was consistently the most common reason to seek help about vaccines in this study highlights that myths, unless dispelled by sources trusted by consumers, can persist as a barrier to immunisation. Luthy et al. 7 found that thiomersal was also a concern in vaccine hesitant parents in the United States. If health professionals are aware of this pervasive concern, they could proactively provide parents with evidence and reassurance that registered Australian vaccines used as part of the national immunisation program are thiomersal and mercury free.
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United States literature suggests that the varicella vaccine is the most common childhood vaccine to raise parental concerns, 13 especially regarding its safety and effectiveness. In our study, enquiries about the MMR vaccine were more common (30%) followed by the combined diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, Haemophilus influenza type b vaccine (19%) and the varicella vaccine (18%). The different outcomes of our Australian study might be explained by the way the cohort was derived. Gust and colleagues 13 formed their cohort by random-digit-dialling methods and asked parents about their vaccine doubts. In contrast, our cohort consisted of actively help-seeking parents or carers. This could explain the predominance of the MMR vaccine over the varicella vaccine in our study. The MMR vaccine has been surrounded by controversy due to the infamous Wakefield study. 37 Despite the fact that this study was openly discredited, the original unfounded message still pervades. 
Peak of interest in childhood vaccines
Strengths and limitations
This study's major strength is that data from consumer calls asking about childhood vaccines were collected for eight years. These questions display the real life information needs of consumers concerning childhood immunisation. Some of these questions might never reach a health professional, so being aware of these information needs could be valuable for every health professional dealing with childhood vaccinations.
The MCC repository was designed for service rather than for research purposes. As a result, there are missing demographic data. Data were entered and calls were answered by different pharmacists which could have resulted in differences the documentation of the narrative of the call. Nevertheless, these data provide a valuable source for identifying the real world vaccine-related information needs of help seeking consumers.
While key themes were identified for the cohort as a whole; only the statistically significant difference between the high and low immunisation groups was increased interest in thiomersal and mercury in vaccines in the low immunisation group. A larger sample of question narratives from groups of immunisation acceptors and rejecters may have had the power to detect other theme differences. Future studies should focus on the exploring differences between these groups in order to better target information needs of people in areas with low immunisation coverage.
We do not know whether the information needs of people who did not contact the MCC are similar to the people who called the service. People with different attitudes towards vaccination use different information sources. 34 People who don't vaccinate their children are more likely to use other sources than their GP, such as the internet; while people who vaccinate their children are more likely to trust their GP regarding immunisation. 34 The large number and consistency of questions asked over eight years by Australian consumers who expressed information gaps and concerns about vaccines contributes to a better understanding of their information needs. Future studies about health information seeking in relation to childhood vaccines should include the vaccination status of the patient. This will more clearly differentiate the information needs of those who do and do not immunise their child.
Conclusion
The overwhelming reason for Australian consumers to contact a MCC with a question about vaccines for young children was safety. Vaccine constituents posed a major concern, with the fear of thiomersal or mercury preservatives in the vaccine, significantly more prevalent in areas of low vaccination status, even though these components have already been excluded from vaccines for many years. Similarly, misinformation about the MMR vaccine still pervades, resulting in a higher proportion of questions compared with other vaccines.
For health professionals, it is important to know the immunisation rate in their local area and the associated carer concerns that act as barriers to vaccination uptake for patients in their practice. Once these information gaps and concerns are identified, health professionals will be in a position to proactively tailor their approach and provide information to their patients to address these information-related barriers to vaccination.
